NCT06261866 (MultiInter-CCS) is a clinical trial in Chronic Coronary Syndrome, sponsored by Medical University of Warsaw.

Who is sponsoring NCT06261866?

NCT06261866 is sponsored by Medical University of Warsaw.

What condition does NCT06261866 study?

NCT06261866 studies Chronic Coronary Syndrome.

Is NCT06261866 still recruiting?

NCT06261866 is currently recruiting now. Last updated 15 February 2024.

Last reviewed 2024-02-15 · How we verify

NCT06261866: MultiInter-CCS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multimodality Imaging and Functional Lesion Assessment in Intermediate Coronary Stenosis in Chronic Coronary Syndrome

Recruiting now Last updated 15 February 2024

What this trial tests

trial in Chronic Coronary Syndrome in 200 participants. Currently enrolling.

Timeline

7 April 2011

Primary endpoint
31 December 2024

31 December 2028

Quick facts

Lead sponsor	Medical University of Warsaw
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	200
Start date	7 April 2011
Primary completion	31 December 2024
Estimated completion	31 December 2028
Sites	1 location across Poland

Conditions studied

Chronic Coronary Syndrome — all drugs for Chronic Coronary Syndrome →

Sponsor

Medical University of Warsaw

Who can join

18 and older, any sex, with Chronic Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this prospective, investigator-initiated study is to evaluate the diagnostic accuracy and correlations between functional indices (fractional flow reserve, FFR) and morphometric indices: luminal and qualitative parameters assessed by optical coherence tomography (OCT) including minimal lumen area, plaque type, presence of thin cap fibroatheroma among patients with chronic coronary syndrome identified with intermediate grade coronary stenosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate Coronary Artery Lesions.
Baruś P, Hunia J, Kaczorowski R, Bednarek A, et al · · 2024 · cited 1× · PMID 38720443 · DOI 10.12659/msm.943956

Verify or expand the search:

Other recruiting trials for Chronic Coronary Syndrome

Currently open trials in the same condition.

NCT07195149 — Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Followin · Phase 3 · recruiting
NCT07182799 — Starring Optical Coherence Tomography During Percutaneous Coronary Intervention Guidance · active not recruiting
NCT07291609 — Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes · recruiting
NCT06896708 — Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patie · NA · recruiting
NCT07020858 — FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion · recruiting

Other Medical University of Warsaw trials

Trials by the same sponsor.

NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06261866 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
Last refreshed: 15 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06261866.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing